Literature DB >> 15322158

A novel mutation in CD83 results in the development of a unique population of CD4+ T cells.

Leon F García-Martínez1, Mark W Appleby, Karen Staehling-Hampton, Dawn M Andrews, Yuching Chen, Mark McEuen, Phuong Tang, Rebecca L Rhinehart, Sean Proll, Bryan Paeper, Mary E Brunkow, Andres G Grandea, Edward D Howard, Don E Walker, Patrick Charmley, Mechthild Jonas, Stevan Shaw, John A Latham, Fred Ramsdell.   

Abstract

Using a mouse mutagenesis screen, we have identified CD83 as being critical for the development of CD4(+) T cells and for their function postactivation. CD11c(+) dendritic cells develop and function normally in mice with a mutated CD83 gene but CD4(+) T cell development is substantially reduced. Additionally, we now show that those CD4(+) cells that develop in a CD83 mutant animal fail to respond normally following allogeneic stimulation. This is at least in part due to an altered cytokine expression pattern characterized by an increased production of IL-4 and IL-10 and diminished IL-2 production. Thus, in addition to its role in selection of CD4(+) T cells, absence of CD83 results in the generation of cells with an altered activation and cytokine profile.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15322158     DOI: 10.4049/jimmunol.173.5.2995

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

Review 1.  Dendritic cell CD83: a therapeutic target or innocent bystander?

Authors:  Charlene M Prazma; Thomas F Tedder
Journal:  Immunol Lett       Date:  2007-10-29       Impact factor: 3.685

2.  Th-1 polarization is regulated by dendritic-cell comparison of MHC class I and class II antigens.

Authors:  William K Decker; Dongxia Xing; Sufang Li; Simon N Robinson; Hong Yang; David Steiner; Krishna V Komanduri; Elizabeth J Shpall
Journal:  Blood       Date:  2009-01-26       Impact factor: 22.113

3.  CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10-driven MARCH1-mediated ubiquitination and degradation.

Authors:  Lina E Tze; Keisuke Horikawa; Heather Domaschenz; Debbie R Howard; Carla M Roots; Robert J Rigby; David A Way; Mari Ohmura-Hoshino; Satoshi Ishido; Christopher E Andoniou; Mariapia A Degli-Esposti; Christopher C Goodnow
Journal:  J Exp Med       Date:  2011-01-10       Impact factor: 14.307

4.  Cytomegalovirus mediates expansion of IL-15-responsive innate-memory cells with SIV killing function.

Authors:  Gema Méndez-Lagares; Ning Chin; W L William Chang; Jaewon Lee; Míriam Rosás-Umbert; Hung T Kieu; David Merriam; Wenze Lu; Sungjin Kim; Lourdes Adamson; Christian Brander; Paul A Luciw; Peter A Barry; Dennis J Hartigan-O'Connor
Journal:  J Clin Invest       Date:  2021-08-02       Impact factor: 14.808

5.  The CD83 reporter mouse elucidates the activity of the CD83 promoter in B, T, and dendritic cell populations in vivo.

Authors:  Matthias Lechmann; Naomi Shuman; Andrew Wakeham; Tak W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-13       Impact factor: 11.205

6.  Altered heme-mediated modulation of dendritic cell function in sickle cell alloimmunization.

Authors:  Emmanuelle Godefroy; Yunfeng Liu; Patricia Shi; W Beau Mitchell; Devin Cohen; Stella T Chou; Deepa Manwani; Karina Yazdanbakhsh
Journal:  Haematologica       Date:  2016-05-26       Impact factor: 9.941

7.  Targeting CD83 for the treatment of graft-versus-host disease.

Authors:  Xiongfei Wang; Ming Q Wei; Xiaosong Liu
Journal:  Exp Ther Med       Date:  2013-04-02       Impact factor: 2.447

8.  Unique properties of thymic antigen-presenting cells promote epigenetic imprinting of alloantigen-specific regulatory T cells.

Authors:  Garima Garg; Eirini Nikolouli; Matthias Hardtke-Wolenski; Aras Toker; Naganari Ohkura; Michael Beckstette; Takahisa Miyao; Robert Geffers; Stefan Floess; Norbert Gerdes; Esther Lutgens; Anke Osterloh; Shohei Hori; Shimon Sakaguchi; Elmar Jaeckel; Jochen Huehn
Journal:  Oncotarget       Date:  2017-05-30

9.  CD83 modulates B cell function in vitro: increased IL-10 and reduced Ig secretion by CD83Tg B cells.

Authors:  Birte Kretschmer; Katja Lüthje; Andreas H Guse; Svenja Ehrlich; Friedrich Koch-Nolte; Friedrich Haag; Bernhard Fleischer; Minka Breloer
Journal:  PLoS One       Date:  2007-08-15       Impact factor: 3.240

10.  Thymic CD4 T cell selection requires attenuation of March8-mediated MHCII turnover in cortical epithelial cells through CD83.

Authors:  Julia von Rohrscheidt; Elisabetta Petrozziello; Jelena Nedjic; Christine Federle; Lena Krzyzak; Hidde L Ploegh; Satoshi Ishido; Alexander Steinkasserer; Ludger Klein
Journal:  J Exp Med       Date:  2016-08-08       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.